An Organic CD4 Inhibitor Reduces the Clinical and Pathological Symptoms of Acute Experimental Allergic Encephalomyelitis

This publication has 36 references indexed in Scilit:

• Oral delivery of xeno-antigen combined with non-depleting anti-CD4 monoclonal antibody induces significantly prolonged survival of concordant skin xenograft
  Xenotransplantation, 2001
• Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation.
  The Journal of Experimental Medicine, 1995
• Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
  Neurology, 1995
• Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor.
  The Journal of Experimental Medicine, 1994
• EVIDENCE THAT LONG-TERM CARDIAC ALLOGRAFT SURVIVAL INDUCED BY ANTI-CD4 MONOCLONAL ANTIBODY DOES NOT REQUIRE DEPLETION OF CD4+ T CELLS
  Transplantation, 1992
• Mutational analysis of the interaction between CD4 and class II MHC: Class II antigens contact CD4 on a surface opposite the gp120-binding site
  Cell, 1991
• The induction of skin graft tolerance in major histocompatibility complex‐mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti‐CD4 and anti‐CD8 antibodies
  European Journal of Immunology, 1990
• The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck
  Cell, 1988
• Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
  Nature, 1984
• Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions
  Science, 1983